TY - CHAP
T1 - Urge incontinence and gastrointestinal symptoms in adult patients with pompe disease
T2 - A cross-sectional survey
AU - Karabul, Nesrin
AU - Skudlarek, Anika
AU - Berndt, Janine
AU - Kornblum, Cornelia
AU - Kley, Rudolf A.
AU - Wenninger, Stephan
AU - Tiling, Nikolaus
AU - Mengel, Eugen
AU - Plöckinger, Ursula
AU - Vorgerd, Matthias
AU - Deschauer, Marcus
AU - Schoser, Benedikt
AU - Hanisch, Frank
N1 - Publisher Copyright:
© 2014, SSIEM and Springer-Verlag Berlin Heidelberg.
PY - 2014
Y1 - 2014
N2 - Objective: To determine the frequency and impact of gastrointestinal symptoms, and bowel and urinary incontinence, as this is currently unknown in adults with Pompe disease. Methods: Adult German Pompe patients and age- and gender-matched controls were asked about symptoms in the upper and lower intestinal tract as well as urinary incontinence using the Gastrointestinal Symptoms Questionnaire and the International Consultation on Incontinence Questionnaires for Bowel Symptoms and Urinary Incontinence. Results: The overall response rate was 78%; 57 patients and 57 controls participated. The mean age of the patients was 48.3 years ±14.7 (28 female, 29 male). 84% of patients were receiving enzyme replacement therapy. Stool urgency, diarrhoea, and urinary urge incontinence were reported significantly more frequently in patients compared to the age- and gender-matched controls (55%, 56%, 33% vs. 20%, 18%, 7%). 20% of Pompe patients used loperamide daily against diarrhoea. No other gastrointestinal tract-related symptoms were reported to occur more frequently in Pompe patients than in controls. Conclusions: Compared to age- and gender-matched controls, both urinary and bowel incontinence occur in a higher frequency in adults with Pompe disease and have a major impact on daily life.
AB - Objective: To determine the frequency and impact of gastrointestinal symptoms, and bowel and urinary incontinence, as this is currently unknown in adults with Pompe disease. Methods: Adult German Pompe patients and age- and gender-matched controls were asked about symptoms in the upper and lower intestinal tract as well as urinary incontinence using the Gastrointestinal Symptoms Questionnaire and the International Consultation on Incontinence Questionnaires for Bowel Symptoms and Urinary Incontinence. Results: The overall response rate was 78%; 57 patients and 57 controls participated. The mean age of the patients was 48.3 years ±14.7 (28 female, 29 male). 84% of patients were receiving enzyme replacement therapy. Stool urgency, diarrhoea, and urinary urge incontinence were reported significantly more frequently in patients compared to the age- and gender-matched controls (55%, 56%, 33% vs. 20%, 18%, 7%). 20% of Pompe patients used loperamide daily against diarrhoea. No other gastrointestinal tract-related symptoms were reported to occur more frequently in Pompe patients than in controls. Conclusions: Compared to age- and gender-matched controls, both urinary and bowel incontinence occur in a higher frequency in adults with Pompe disease and have a major impact on daily life.
KW - Enzyme replacement therapy
KW - Fabry disease
KW - Gauche disease
KW - Pompe disease
KW - Urinary incontinence
UR - http://www.scopus.com/inward/record.url?scp=84919380349&partnerID=8YFLogxK
U2 - 10.1007/8904_2014_334
DO - 10.1007/8904_2014_334
M3 - Chapter
AN - SCOPUS:84919380349
T3 - JIMD Reports
SP - 53
EP - 61
BT - JIMD Reports
PB - Springer
ER -